Clinical Trials
13 trialsNCT07379125 2026-05-22
Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Phase 1 Recruiting
NCT07575854 2026-05-13
SPLENIC-SIRT
Centre Georges Francois Leclerc
Phase NA Not yet recruiting
NCT05992532 2026-02-11
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Fundación Española de Hematología y Hemoterapía
Recruiting
NCT03895112 2023-02-10
MPN-RC 118 AVID200 in Myelofibrosis
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT02055781 2021-11-18
PAC326
CTI BioPharma
Phase 3 Terminated
NCT04716166 2021-10-20
Incentive Spirometry and Upper Abdominal Laparoscopic Surgery
Riphah International University
Phase NA Completed
NCT02948283 2021-02-12
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT01773187 2020-09-29
Pacritinib Versus Best Available Therapy to Treat Myelofibrosis
CTI BioPharma
Phase 3 Terminated
NCT04524650 2020-08-28
Early Diagnosis of Oxaliplatin-induced Portal Hypertension
Shanghai Zhongshan Hospital
Unknown
NCT04524676 2020-08-24
Oxaliplatin-induced Portal Hypertension
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT02730884 2020-08-07
Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02421354 2019-05-15
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01201655 2010-09-14
Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
Xijing Hospital
Unknown